Twelve-Month Durability of Microbiota-Based Drug RBX2660 for Preventing Clostridioides difficile Infection (CDI) Is Not Associated With Patient Demographics: Sub-Population Analysis of a Phase 2 Open-Label Study Article

Full Text via DOI: 10.14309/ Web of Science: 000509756006322

Cited authors

  • Ray, Arnab; Mische, Sarah; Blount, Ken; Bancke, Lindy; Su, Xin; Harvey, Adam; Gerding, Dale


Publication date

  • 2019

Published in

International Standard Serial Number (ISSN)

  • 0002-9270

Start page

  • S1555

End page

  • S1556


  • 114